LLY

Eli Lilly and Company

Biotechnology

Instead of Chasing Every New Vaccine "Breakthrough," Trade the Whole Sector

Not every biotech company is doing well in the search for an effective COVID-19 vaccine or treatment.

And the latest firm to struggle is Eli Lilly, whose antibody clinical trial was paused due to failure to show any real results.

So today, Andrew's going to show you a much more profitable move to make instead of chasing every vaccine "breakthrough" news…

Read more...

Technology

The Answer to Big Pharma's Biggest Problem Could Double Your Money in Just Three Years

You could forgive drug and biotech executives for having a bad case of target fixation.

After all, they do work in a field that is filled with time-consuming and expensive headaches.

Consider that the Biotechnology Innovation Organization (BIO), the world's largest biotech trade organization, looked at 7,400 drug programs by 1,103 companies. They were investigating drug-approval rates.

The news was not good -just 9.6% of drugs scientists discover ever get approved for sale. That's a one-in-ten shot.

With such daunting data, it's no wonder that, even in a field already worth $1.2 trillion in global sales, industry leaders are on the lookout for ways to lower the cost of discovery and shorten time to market.

And with that goal in mind, I've uncovered a high-octane, large-cap firm that has become an essential ingredient in the drug sector's success.

It's a cloud-based leader in pharmaceutical efficiency that has a history of crushing the market by no small measure.

And it's been doubling its earnings, on average, every 18 months...

Dow Jones

Dow Jones Today Rallies After Donald Trump's State of the Union Address

The Dow Jones today rebounds from a brutal two-day selloff fueled by concerns about rising bond yields.

Dow futures are up 213 points in premarket hours as investors weighed on President Donald Trump's first State of the Union Address. Automatic Data Processing reported that private payrolls increased by 234,000 in January, topping average expectations of 185,000.

Here's a look at today's most important market events and stocks, plus a look at today's economic calendar...